Chest Care by Dr Saima Jatoi

22/08/2026

Academic Seminar on Asthma Management & Contemporary Respiratory Care

An informative and academically enriching seminar was organized by Hudson Pharma at Royal Taj Hotel, Hyderabad, focusing on the contemporary management of bronchial asthma and the evidence-based use of Levabuterol and Budesonide in respiratory practice.

The scientific session was conducted by Dr. Saima Jatoi, who delivered an in-depth presentation on the pharmacological profile, clinical applications, therapeutic benefits, and appropriate use of Levabuterol and Budesonide. She also provided a comprehensive overview of the Global Initiative for Asthma (GINA) guidelines, highlighting current principles of asthma diagnosis, assessment of disease control, risk assessment, stepwise pharmacological management, and individualized treatment strategies.

The seminar was attended by consultants, postgraduate trainees, and house officers, providing an excellent platform for academic interaction, clinical discussion, and exchange of contemporary knowledge in pulmonology and respiratory medicine.

The academic session concluded with an interactive knowledge-based quiz, allowing participants to consolidate their learning and assess their understanding of asthma management, GINA recommendations, and the therapeutic role of Levabuterol and Budesonide.

The seminar served as a valuable platform for continuing medical education, professional development, and promotion of evidence-based respiratory care.

We sincerely appreciate Hudson Pharma for organizing this valuable academic initiative and Dr. Saima Jatoi for her insightful presentation and contribution toward enhancing clinical knowledge and awareness in respiratory medicine.

Venue: Royal Taj Hotel, Hyderabad

14/08/2026

Happy Independence Day 💚

02/08/2026

The Pulmonology Department, Isra University Hospital (IUH), Hyderabad, in collaboration with Horizon Pharma, successfully organized an educational seminar highlighting the latest evidence and clinical applications of lefamulin, a novel pleuromutilin antibiotic approved for the treatment of community-acquired bacterial pneumonia (CABP).

The scientific session was organized and delivered by Dr. Saima Jatoi, whose dedication to advancing medical education continues to strengthen the academic environment within the department.

The presentation provided a comprehensive overview of lefamulin, including its unique mechanism of action, spectrum of activity against common respiratory pathogens, including atypical organisms, its clinical indications, efficacy demonstrated in major clinical trials, safety profile, dosing considerations, and its role in evidence-based management of community-acquired bacterial pneumonia. The discussion also emphasized the importance of appropriate antibiotic selection and antimicrobial stewardship in improving patient outcomes while helping combat antimicrobial resistance.

Dr. Saima Jatoi delivered an engaging, evidence-based presentation that translated current scientific knowledge into practical clinical decision-making. Through her continued commitment to postgraduate teaching, mentorship, and academic leadership, she has consistently fostered a culture of lifelong learning within the Pulmonology Department. Her efforts to organize educational activities, encourage critical appraisal of emerging therapies, and promote evidence-based respiratory care continue to benefit postgraduate trainees, house officers, medical officers, and ultimately the community through enhanced standards of patient care.

The seminar witnessed enthusiastic participation from postgraduate trainees, house officers, and medical officers. An interactive quiz session further enriched the learning experience, encouraging active participation, discussion, and reinforcement of key clinical concepts.

The evening concluded with a delightful dinner, providing an opportunity for colleagues to strengthen professional relationships and celebrate the spirit of collaboration beyond the academic setting.

The Pulmonology Department extends its sincere appreciation to Horizon Pharma for supporting this valuable educational initiative and expresses heartfelt gratitude to Dr. Saima Jatoi for her unwavering dedication to academic excellence, mentorship, and the advancement of respiratory medicine.

"Education is the foundation of excellence in patient care, and every scientific discussion brings us one step closer to better outcomes for our patients."

26/07/2026

24/07/2026

Pneumonia occurring before or within 48 hours of hospital admission.

Common Organisms

• Streptococcus pneumoniae (most common)
• Haemophilus influenzae
• Staphylococcus aureus
• Moraxella catarrhalis
• Mycoplasma pneumoniae
• Respiratory viruses (Influenza virus, RSV)

---

# # Hospital-Acquired Pneumonia (HAP)

Definition

Pneumonia developing 48 hours or more after hospital admission and was not incubating at the time of admission.

Common Organisms

• Staphylococcus aureus (including MRSA)
• Pseudomonas aeruginosa
• Klebsiella pneumoniae
• Escherichia coli
• Acinetobacter species

---

# # Streptococcus pneumoniae

• Most common cause of community-acquired pneumonia.
• Gram-positive lancet-shaped diplococci.
• Produces rust-colored sputum.
• Common in elderly, alcoholics, post-splenectomy patients, immunocompromised patients, and those with chronic heart or lung disease.
• May cause bacteremia, meningitis, empyema, and pleural effusion.

---

# # Staphylococcus aureus

• Gram-positive cocci in clusters.
• Most common cause of secondary bacterial pneumonia following influenza.
• Seen in intravenous drug users, diabetics, cystic fibrosis patients, and immunocompromised individuals.
• Causes lung abscess, cavitary pneumonia, empyema, and pneumatoceles.

---

# # Klebsiella pneumoniae

• Gram-negative encapsulated bacillus.
• Common in alcoholics, diabetics, elderly, and debilitated patients.
• Produces thick red currant-jelly sputum.
• Causes severe necrotizing pneumonia with upper lobe cavitation.
• Frequently multidrug resistant.

---

# # Pseudomonas aeruginosa

• Gram-negative rod.
• Produces green sputum due to pyocyanin pigment.
• Important cause of hospital-acquired pneumonia.
• Most common pathogen in cystic fibrosis.
• Common in bronchiectasis, ventilated patients, and immunocompromised individuals.
• Causes severe necrotizing pneumonia with high mortality.

---

# # Mycoplasma pneumoniae

• Smallest free-living bacterium.
• Has no cell wall; therefore penicillins and cephalosporins are ineffective.
• Causes atypical pneumonia.
• Presents with fever, headache, malaise, myalgia, sore throat, and dry cough.
• Diagnosis is by PCR or serology.
• Cold agglutinins may cause autoimmune hemolytic anemia.
• Associated with erythema multiforme, Stevens–Johnson syndrome, Guillain–Barré syndrome, encephalitis, and myocarditis.

---

# # Legionella pneumophila

• Found in contaminated water systems, cooling towers, air-conditioning systems, and hot water tanks.
• Causes Legionnaires' disease.
• Presents with high fever, dry cough, dyspnea, myalgia, and headache.
• Extrapulmonary manifestations include diarrhea, abdominal pain, confusion, and neurological symptoms.
• Laboratory findings include hyponatremia and elevated liver enzymes.
• Diagnosis is by urinary antigen test, culture on BCYE agar, or PCR.
• Treatment is azithromycin or levofloxacin.

---

# # Haemophilus influenzae

• Gram-negative coccobacillus.
• Common in smokers and patients with COPD.
• Important bacterial cause of acute exacerbation of COPD.
• Most common organism isolated in non-cystic fibrosis bronchiectasis.
• May cause otitis media, sinusitis, epiglottitis, and pneumonia.

---

# # High-Yield IMM/FCPS Pearls

• Most common cause of community-acquired pneumonia: Streptococcus pneumoniae.
• Most common bacterial pneumonia after influenza: Staphylococcus aureus.
• Rust-colored sputum: Streptococcus pneumoniae.
• Currant-jelly sputum: Klebsiella pneumoniae.
• Green sputum: Pseudomonas aeruginosa.
• No cell wall: Mycoplasma pneumoniae.
• Air conditioner-associated pneumonia: Legionella pneumophila.
• Pneumonia with hyponatremia: Legionella pneumophila.
• Common bacterial cause of acute exacerbation of COPD: Haemophilus influenzae.
• Most common pathogen in cystic fibrosis: Pseudomonas aeruginosa.
• Most common organism isolated in non-cystic fibrosis bronchiectasis: Haemophilus influenzae.
• Pneumonia with upper lobe cavitation in alcoholics: Klebsiella pneumoniae.